129 related articles for article (PubMed ID: 26302991)
21. Spotlighting the role of photodynamic therapy in cutaneous malignancy: an update and expansion.
Ross K; Cherpelis B; Lien M; Fenske N
Dermatol Surg; 2013 Dec; 39(12):1733-44. PubMed ID: 24118243
[TBL] [Abstract][Full Text] [Related]
22. Lack of T-cell receptor-induced signaling is crucial for CD95 ligand up-regulation and protects cutaneous T-cell lymphoma cells from activation-induced cell death.
Klemke CD; Brenner D; Weiss EM; Schmidt M; Leverkus M; Gülow K; Krammer PH
Cancer Res; 2009 May; 69(10):4175-83. PubMed ID: 19435902
[TBL] [Abstract][Full Text] [Related]
23. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.
Mitsiades N; Poulaki V; Tseleni-Balafouta S; Koutras DA; Stamenkovic I
Cancer Res; 2000 Aug; 60(15):4122-9. PubMed ID: 10945619
[TBL] [Abstract][Full Text] [Related]
24. Pentoxifylline augments TRAIL/Apo2L mediated apoptosis in cutaneous T cell lymphoma (HuT-78 and MyLa) by modulating the expression of antiapoptotic proteins and death receptors.
Gahlot S; Khan MA; Rishi L; Majumdar S
Biochem Pharmacol; 2010 Dec; 80(11):1650-61. PubMed ID: 20804743
[TBL] [Abstract][Full Text] [Related]
25. Activation of two caspase cascades, caspase 8/3/6 and caspase 9/3/6, during photodynamic therapy using a novel photosensitizer, ATX-S10(Na), in normal human keratinocytes.
Takahashi H; Itoh Y; Miyauchi Y; Nakajima S; Sakata I; Ishida-Yamamoto A; Iizuka H
Arch Dermatol Res; 2003 Nov; 295(6):242-8. PubMed ID: 13680269
[TBL] [Abstract][Full Text] [Related]
26. Involvement of Fas (APO-1/CD-95) during photodynamic-therapy-mediated apoptosis in human epidermoid carcinoma A431 cells.
Ahmad N; Gupta S; Feyes DK; Mukhtar H
J Invest Dermatol; 2000 Dec; 115(6):1041-6. PubMed ID: 11121139
[TBL] [Abstract][Full Text] [Related]
27. Reciprocal modulation of circulating CD4+CD25+bright T cells induced by extracorporeal photochemotherapy in cutaneous T-cell lymphoma and chronic graft-versus-host-disease patients.
Quaglino P; Comessatti A; Ponti R; Peroni A; Mola F; Fierro MT; Savoia P; Novelli M; Bernengo MG
Int J Immunopathol Pharmacol; 2009; 22(2):353-62. PubMed ID: 19505389
[TBL] [Abstract][Full Text] [Related]
28. Lamin A/C cleavage by caspase-6 activation is crucial for apoptotic induction by photodynamic therapy with hexaminolevulinate in human B-cell lymphoma cells.
Shahzidi S; Brech A; Sioud M; Li X; Suo Z; Nesland JM; Peng Q
Cancer Lett; 2013 Oct; 339(1):25-32. PubMed ID: 23916608
[TBL] [Abstract][Full Text] [Related]
29. Apoptosis induction by SAHA in cutaneous T-cell lymphoma cells is related to downregulation of c-FLIP and enhanced TRAIL signaling.
Al-Yacoub N; Fecker LF; Möbs M; Plötz M; Braun FK; Sterry W; Eberle J
J Invest Dermatol; 2012 Sep; 132(9):2263-74. PubMed ID: 22551975
[TBL] [Abstract][Full Text] [Related]
30. Expression of apoptosis markers on peripheral blood lymphocytes from patients with cutaneous T-cell lymphoma during extracorporeal photochemotherapy.
Osella-Abate S; Zaccagna A; Savoia P; Quaglino P; Salomone B; Bernengo MG
J Am Acad Dermatol; 2001 Jan; 44(1):40-7. PubMed ID: 11148475
[TBL] [Abstract][Full Text] [Related]
31. 5-aminolevulinic acid induce apoptosis via NF-κB/JNK pathway in human oral cancer Ca9-22 cells.
Chen HM; Liu CM; Yang H; Chou HY; Chiang CP; Kuo MY
J Oral Pathol Med; 2011 Jul; 40(6):483-9. PubMed ID: 21138480
[TBL] [Abstract][Full Text] [Related]
32. Resistance of T-cell acute lymphoblastic leukemia to tumor necrosis factor--related apoptosis-inducing ligand-mediated apoptosis.
Akahane K; Inukai T; Zhang X; Hirose K; Kuroda I; Goi K; Honna H; Kagami K; Nakazawa S; Endo K; Kubota T; Yagita H; Koyama-Okazaki T; Sugita K
Exp Hematol; 2010 Oct; 38(10):885-95. PubMed ID: 20670671
[TBL] [Abstract][Full Text] [Related]
33. Proteasome inhibition as a novel mechanism of the proapoptotic activity of γ-secretase inhibitor I in cutaneous T-cell lymphoma.
Biskup E; Kamstrup MR; Manfé V; Gniadecki R
Br J Dermatol; 2013 Mar; 168(3):504-12. PubMed ID: 23445313
[TBL] [Abstract][Full Text] [Related]
34. The inhibition of ferrochelatase enhances 5-aminolevulinic acid-based photodynamic action for prostate cancer.
Fukuhara H; Inoue K; Kurabayashi A; Furihata M; Fujita H; Utsumi K; Sasaki J; Shuin T
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):399-409. PubMed ID: 24284092
[TBL] [Abstract][Full Text] [Related]
35. Combination of retinoid and histone deacetylase inhibitor produced an anti-tumor effect in cutaneous T-cell lymphoma by restoring tumor suppressor gene, retinoic acid receptorβ2, via histone acetylation.
Kato Y; Egusa C; Maeda T; Tsuboi R
J Dermatol Sci; 2016 Jan; 81(1):17-25. PubMed ID: 26596218
[TBL] [Abstract][Full Text] [Related]
36. Recombinant measles virus induces cytolysis of cutaneous T-cell lymphoma in vitro and in vivo.
Künzi V; Oberholzer PA; Heinzerling L; Dummer R; Naim HY
J Invest Dermatol; 2006 Nov; 126(11):2525-32. PubMed ID: 16960554
[TBL] [Abstract][Full Text] [Related]
37. Activity of deacetylase inhibitor panobinostat (LBH589) in cutaneous T-cell lymphoma models: Defining molecular mechanisms of resistance.
Shao W; Growney JD; Feng Y; O'Connor G; Pu M; Zhu W; Yao YM; Kwon P; Fawell S; Atadja P
Int J Cancer; 2010 Nov; 127(9):2199-208. PubMed ID: 20127862
[TBL] [Abstract][Full Text] [Related]
38. 5-ALA-PDT induces RIP3-dependent necrosis in glioblastoma.
Coupienne I; Fettweis G; Rubio N; Agostinis P; Piette J
Photochem Photobiol Sci; 2011 Dec; 10(12):1868-78. PubMed ID: 22033613
[TBL] [Abstract][Full Text] [Related]
39. Bortezomib inhibits expression of TGF-β1, IL-10, and CXCR4, resulting in decreased survival and migration of cutaneous T cell lymphoma cells.
Chang TP; Poltoratsky V; Vancurova I
J Immunol; 2015 Mar; 194(6):2942-53. PubMed ID: 25681335
[TBL] [Abstract][Full Text] [Related]
40. Large-cell transformation following detection of minimal residual disease in cutaneous T-cell lymphoma: molecular and in situ analysis of a single neoplastic T-cell clone expressing the identical T-cell receptor.
Wolfe JT; Chooback L; Finn DT; Jaworsky C; Rook AH; Lessin SR
J Clin Oncol; 1995 Jul; 13(7):1751-7. PubMed ID: 7602365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
